Clinical Trials
2 trialsNCT03640481 2024-12-12
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Sanofi
Phase 2 Terminated
NCT05382377 2022-05-19
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase EARLY_PHASE1 Unknown